Clinical Trial Update: Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating an HCV antigen peptide vaccine for chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HCV antigen peptide vaccine

Snippet

Sponsor: Valneva Austria GmbH | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED